ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 117 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,711,000 | +18.8% | 972,176 | +595.5% | 0.16% | -34.0% |
| Q3 2020 | $1,440,000 | -57.0% | 139,781 | -12.8% | 0.24% | -57.7% |
| Q2 2020 | $3,345,000 | +56.6% | 160,216 | -26.7% | 0.56% | +13.5% |
| Q1 2020 | $2,136,000 | -21.6% | 218,624 | -7.6% | 0.49% | +106.8% |
| Q4 2019 | $2,725,000 | +136150.0% | 236,583 | +688.6% | 0.24% | +23600.0% |
| Q3 2019 | $2,000 | – | 30,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 5,068,233 | $17,739,000 | 5.88% |
| Sonic Fund II, L.P. | 6,552,068 | $22,932,000 | 1.69% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $1,680,000 | 0.88% |
| Avoro Capital Advisors LLC | 6,950,000 | $24,325,000 | 0.42% |
| RTW INVESTMENTS, LP | 7,357,917 | $25,753,000 | 0.39% |
| K2 PRINCIPAL FUND, L.P. | 898,307 | $3,144,000 | 0.26% |
| Artal Group S.A. | 3,000,000 | $10,500,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,827,000 | $9,895,000 | 0.18% |
| WS MANAGEMENT LLLP | 307,442 | $1,076,000 | 0.11% |
| ALGERT GLOBAL LLC | 82,145 | $288,000 | 0.10% |